13.03MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US09060U5074
CUSIP
14161L109
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-0.33
Dividend Share
-
Dividend Yield
-
Earnings Share
-2.14
Wall Street Target Price
6.00
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
3,000
Gross Profit TTM
-4,673,000
EBITDA
-8,392,000
Profit Margin
0.00%
Return On Assets TTM
-218.06%
Return On Equity TTM
-737.89%
Revenue Per Share TTM
0.001
Qtly Revenue Growth YOY
-100.00%
Diluted Eps TTM
-2.14
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
4343.897
Price Book MRQ
10.6661
Enterprise Value Revenue
4310
Enterprise Value EBITDA
-3
270.00
7.03%160.00
3.92%79.89
0.99%100.98
0.72%547.60
0.00%203.85
0.00%547.75
-4.03%464.03
-1.78%310.44
-1.71%555.50
-1.01%